Bond Teva Pharmaceutical Industries 7.125% ( US88167AAN19 ) in USD

Issuer Teva Pharmaceutical Industries
Market price 100.03 %  ▲ 
Country  Israel
ISIN code  US88167AAN19 ( in USD )
Interest rate 7.125% per year ( payment 2 times a year)
Maturity 01/29/2025 - Bond has expired
Minimal amount /
Total amount /
Cusip 88167AAN1
Standard & Poor's ( S&P ) rating BB ( Non-investment grade speculative )
Moody's rating Ba2 ( Non-investment grade speculative )
Detailed description Teva Pharmaceutical Industries is a global pharmaceutical company specializing in generic and specialty medications, with a focus on central nervous system disorders, respiratory diseases, oncology, and women's health.

Teva Pharmaceutical Industries (ISIN: US88167AAN19, CUSIP: 88167AAN1) issued a USD-denominated bond currently trading at 99.133%, offering a 7.125% coupon with semi-annual payments, maturing on January 29, 2025, and rated BB- by S&P and Ba2 by Moody's.
DateClean price
01/10/2025100.03%
11/12/202499.13%
09/26/2024100.13%
08/18/2024100.44%
08/07/2024100.00%
06/25/2024100.44%
09/10/2023100.50%
08/15/2023101.75%
07/23/2023101.75%
06/29/2023101.75%
06/05/2023101.75%
05/12/2023101.75%
04/19/2023101.75%
04/01/2023101.75%
03/12/2023100.75%
02/18/202399.75%
01/28/2023101.38%
01/06/202399.75%
12/15/2022101.50%
11/23/202299.88%
11/01/202299.13%
10/13/202299.13%
09/25/202299.25%
09/07/202299.50%
08/22/2022102.13%
08/06/2022102.13%
07/22/202299.63%
07/07/202297.75%
06/22/202298.13%
06/08/2022101.25%
05/24/2022100.38%
05/09/2022100.13%
04/24/2022103.25%
04/08/2022105.00%
03/24/2022103.50%
03/09/2022103.00%
02/21/2022104.75%
02/02/2022104.88%
01/18/2022106.88%
12/29/2021108.63%
12/12/2021108.00%
11/25/2021107.38%
11/11/2021108.00%
10/28/2021108.00%
10/14/2021109.00%
10/01/2021109.25%
09/12/2021109.25%
08/28/2021109.00%
08/16/2021109.75%
08/04/2021110.50%
07/23/2021109.00%
07/11/2021109.25%
06/27/2021110.00%
06/13/2021111.75%
05/26/2021109.75%
05/08/2021109.00%
04/18/2021111.75%
04/01/2021111.00%